“Immune Evasion and Resistance in Cancer Progression: Overcoming Checkpoint Inhibition Challenges with Personalized Immunotherapy Guided by PD-L1 Expression” (2025) Journal of Analytical Oncology, 14, pp. 49–61. doi:10.30683/1927-7229.2025.14.09.